Abstract | BACKGROUND: AIMS: We aimed to analyze the relationship between serum biomarkers and interstitial fibrosis, as assessed with cardiac magnetic resonance (CMR) in HCM patients. METHODS: RESULTS: The final study population included 49 patients. The median value of ECV in our cohort was 28.1%. Patients stratified according to median ECV differed in terms of several variables: body mass index, late gadolinium extent, NT-proBNP, and galectin-3 levels (all P <0.05). Cardiac biomarkers ( TnT and NT-proBNP) and galectin-3 were significantly correlated with ECV (rS = 0.34; P = 0.02; rS = 0.39; P = 0.006; rS = 0.43; P = 0.002, respectively). Galectin-3 and body mass index were found to be independent predictors of ECV (odds ratio [OR], 2.29 [1.07-4.91]; P = 0.03; OR, 0.81 [0.68-0.97]; P = 0.02, respectively). CONCLUSIONS:
Galectin-3 was an independent predictor of interstitial fibrosis in HCM patients expressed as elevated ECV values. The other measured fibrosis-specific biomarkers were not useful in detecting interstitial fibrosis in HCM. In addition, there was a positive correlation between classical cardiac biomarkers and interstitial fibrosis in HCM patients.
|
Authors | Aleksandra Karabinowska-Małocha, Ewa Dziewięcka, Magdalena Szymańska, Paweł Banyś, Małgorzata Urbańczyk-Zawadzka, Maciej Krupiński, Małgorzata Mielnik, Sylwia Wiśniowska-Śmiałek, Piotr Podolec, Aleksandra Budkiewicz, Łukasz Żydzik, Ewa Wypasek, Paweł Rubiś |
Journal | Kardiologia polska
(Kardiol Pol)
Vol. 81
Issue 7-8
Pg. 692-699
( 2023)
ISSN: 1897-4279 [Electronic] Poland |
PMID | 37431248
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Galectin 3
- Procollagen
- Biomarkers
- Contrast Media
|
Topics |
- Humans
- Galectin 3
- Procollagen
- Cardiomyopathy, Hypertrophic
(diagnosis)
- Biomarkers
- Fibrosis
- Myocardium
(pathology)
- Contrast Media
- Predictive Value of Tests
|